Hilar Cholangiocarcinoma clinical trials

Explore recruiting hilar cholangiocarcinoma clinical trials.

Recruiting hilar cholangiocarcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hilar Cholangiocarcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Cholangiocarcinoma treatment with radiofrequency ablation or photodynamic therapy

Germany

Therapeutic use (Phase IV) EU CTIS Study details

ADJUBIL - A Phase II study of immunotherapy with durvalumab and tremelimumab in combination with capecitabine or without capecitabine in ADJUvant situation for BILiary tract cancer

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Hilar Cholangiocarcinoma trials by city

Hilar Cholangiocarcinoma clinical trials

Recruiting hilar cholangiocarcinoma studies right now

Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer

En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve the Overall Survival in Patients With Non-resectable Hilar Cholangiocarcinoma Beyond the Mayo Clinic Transplant Criteria

Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma

Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma

Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study

Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic Therapy

Stereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar Cholangiocarcinoma

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma

LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA)

Also recruiting in Europe

Cholangiocarcinoma treatment with radiofrequency ablation or photodynamic therapy

ADJUBIL - A Phase II study of immunotherapy with durvalumab and tremelimumab in combination with capecitabine or without capecitabine in ADJUvant situation for BILiary tract cancer

Hilar Cholangiocarcinoma trials by city

Other conditions